Clinical Trials in Dallas

Showing 9341-9360 of 17,468 trials

Safety, Tolerability, and Efficacy of Monotherapy and Combination Regimens in Participants With Nonalcoholic Steatohepatitis (NASH)

NCT03987074

The primary objective of this study is to evaluate the safety and tolerability of study drug(s) in participants with nonalcoholic steatohepatitis (NASH).

Nonalcoholic Steatohepatitis

Gilead Sciences109 participantsStarted Jul 2019

Chandler, Arizona, United States • Coronado, California, United States • La Jolla, California, United States +15 more locations

TERMINATEDPhase 2< 1 mile

Efficacy and Safety of LBH589B in Adult Patients With Refractory Chronic Myeloid Leukemia in Accelerated or Blast Phase

NCT00449761

This study will evaluate the efficacy and safety of LBH589B in adult patients with chronic myeloid leukemia who are in accelerated phase or blast phase (blast crisis) with resistant disease following treatment with at least two BCR-ABL tyrosine kinase inhibitors

Leukemia, Myeloid, Chronic

Novartis Pharmaceuticals27 participantsStarted Feb 2007

Duarte, California, United States • Aurora, Colorado, United States • Denver, Colorado, United States +23 more locations

Safety, Tolerability, and Efficacy of Monotherapy and Combination Regimens in Participants With Nonalcoholic Steatohepatitis (NASH)

Efficacy and Safety of LBH589B in Adult Patients With Refractory Chronic Myeloid Leukemia in Accelerated or Blast Phase

Find Trials by Condition in Dallas

Safety and Efficacy Study of GRT6005 in Patients With Osteoarthritis (OA) Knee Pain

Study to Prevent Acute Kidney Injury After Cardiac Surgery Involving Cardiopulmonary Bypass

A Multicenter, Open-Label Retreatment Study of the Safety and Effectiveness of PN40082 for Lip Augmentation

Trial of Extended Release Bupivacaine for Pain Relief After Surgery

A Comparative Study Between Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy Versus Tiotropium Monotherapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects

Efficacy and Safety Study of MYOBLOC® Followed by Open-Label Multiple-Treatment With MYOBLOC® in the Treatment of Troublesome Sialorrhea in Adult Subjects

Risankizumab Versus Secukinumab for Participants With Moderate to Severe Plaque Psoriasis

StrataGraft® Skin Tissue in the Promotion of Autologous Skin Regeneration of Complex Skin Defects Due to Thermal Burns That Contain Intact Dermal Elements

Dose Response of 28 Days of Dosing of GSK962040 in Type I and II Diabetic Male and Female Subjects With Gastroparesis

Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study In Subjects With Osteoarthritic Pain Of The Knee

Healthy Term Infants Fed Milk-Based Infant Formula

Study to Investigate Safety, Pharmacokinetic (PK), Pharmacodynamic (PD) and Clinical Activity of Trametinib in Subjects With Cancer or Plexiform Neurofibromas and Trametinib in Combination With Dabrafenib in Subjects With Cancers Harboring V600 Mutations

Dose Finding Study of Nemiralisib (GSK2269557) in Subjects With an Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)

Dose Escalation Study of AST-OPC1 in Spinal Cord Injury

NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study

Cebranopadol Efficacy and Safety in Diabetic Patients Suffering From Chronic Pain Caused by Damage to the Nerves

Alglucosidase Alfa Pompe Safety Sub-Registry